2019
DOI: 10.3389/fimmu.2019.01723
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Modulation of the Complement Cascade in Stroke

Abstract: Stroke is a leading cause of death and disability worldwide and an increasing number of ischemic stroke patients are undergoing pharmacological and mechanical reperfusion. Both human and experimental models of reperfused ischemic stroke have implicated the complement cascade in secondary tissue injury. Most data point to the lectin and alternative pathways as key to activation, and C3a and C5a binding of their receptors as critical effectors of injury. During periods of thrombolysis use to treat stroke, acute … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
18
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(18 citation statements)
references
References 95 publications
0
18
0
Order By: Relevance
“…Anaphylatoxin C5a is a strong chemoattractant signal that is involved in the regulation of the innate immune system, playing a key role in host homeostasis, inflammation, and defense against pathogens [15][16][17][18][19]. Upon activation through the cleavage of C5 to C5a and C5b by the C5-convertase, C5a takes part in the recruitment and activation of inflammatory cells like neutrophils, eosinophils, T lymphocytes, and monocytes [19,20]. Recently, in a baboon model of Escherichia coli bacteremia, it was shown that complement-mediated bacteriolysis had a detrimental effect by inducing a release of LPS and fulminant inflammation [21].…”
Section: Introductionmentioning
confidence: 99%
“…Anaphylatoxin C5a is a strong chemoattractant signal that is involved in the regulation of the innate immune system, playing a key role in host homeostasis, inflammation, and defense against pathogens [15][16][17][18][19]. Upon activation through the cleavage of C5 to C5a and C5b by the C5-convertase, C5a takes part in the recruitment and activation of inflammatory cells like neutrophils, eosinophils, T lymphocytes, and monocytes [19,20]. Recently, in a baboon model of Escherichia coli bacteremia, it was shown that complement-mediated bacteriolysis had a detrimental effect by inducing a release of LPS and fulminant inflammation [21].…”
Section: Introductionmentioning
confidence: 99%
“…However, other complement activation products may be the most important. 35 Upstream of TCC, the C3 (complement component 3) has been associated with a worse prognosis after ischemic stroke in humans. 14 By contrast, it also seems to play a part in synaptic plasticity and neurogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…Previous in vitro studies using cultured neurons have reported increased C5a expression with oxygen glucose deprivation (OGD) and stress (53), while C5aR1 deletion prevented OGD-induced neuronal apoptosis. Inhibition of C5aR1 has been shown to attenuate apoptotic neuronal cell death in vitro (61), reduces infarct volume in in vivo stroke models (62,63), and improves recovery in a spinal cord injury model (64). Here, we tested whether IAIP treatment alters C5aR1 expression on neutrophils and whether IAIP-induced neuroprotection is mediated via C5aR1 using C5aR1-knockout mice.…”
Section: Discussionmentioning
confidence: 99%